InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
40%
T+90 mean return
-0.9%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Smith Cynthia, Director. Insider active across 5 companies, notably Akebia Therapeutics, Inc.. Aggregated, 17 filings have been logged. History available since 2 June 2021. The latest transaction was disclosed on 11 August 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations17 total
2,816 sharesCommon stockSEC:0001439222-26-000093:0
35,700 sharesCommon StockSEC:0001609480-26-000003:0
2,302 shares0Common stockSEC:0001439222-24-000125:0
3,388 shares0Common stockSEC:0001439222-24-000083:0
30,000 shares0Common StockSEC:0001562180-24-004909:0
20,000 shares0Common StockSEC:0000950170-24-066619:0
20,000 shares0Common StockSEC:0000950170-23-052716:0
2,302 shares0Common stockSEC:0001439222-23-000127:0
30,000 shares0Common StockSEC:0001562180-23-004955:0
15,000 shares0Common StockSEC:0000899243-22-031502:0
13,700 shares0Common StockSEC:0001562180-22-004977:0
3,333 shares@ US$38.2550.0% of flowCommon StockSEC:0001399529-21-000204
3,333 shares@ US$38.2550.0% of flowCommon StockSEC:0001399529-21-000204:0
3,333 sharesCommon StockSEC:0001399529-21-000110:0
3,333 sharesCommon StockSEC:0001399529-21-000110
13,700 shares0Common StockSEC:0001562180-21-004030:0
13,700 shares0Common StockSEC:0001562180-21-004030
17 of 17 declarations
About Smith Cynthia
Cynthia Smith is a Board Member at Akebia Therapeutics, Inc. and Dicerna Pharmaceuticals Inc. She brings her expertise in corporate governance and strategy, contributing to the direction and decision-making within these organizations. Her role involves overseeing operations and ensuring compliance with regulatory standards while supporting the mission of the companies in the biopharmaceutical sector.
